DCC2118 |
Fk1012-a |
Highly potent membrane-permeable ligand of the immunophilin FKBP12, creating a new composite FKBP12-FK506 surface and inactivating calcineurin, a Ca calmodulin-dependent protein phosphatase |
|
DCC2119 |
Fk-3657 |
Novel non-peptide bradykinin (BK)-B2 receptor antagonist |
|
DCC2120 |
Fkbp12-in-q2 |
Novel Inhibitor of FKBP12 |
|
DCC2121 |
Flaviviruses-inhibitor-i |
Specific inhibitor of several viruses belonging to the family of flaviviridae |
|
DCC2122 |
Flemingin A |
Natural anticancer and antioxidant |
|
DCC2123 |
Flg249 |
Novel, potent, orally active, and nonsteroidal farnesoid X receptor (FXR) antagonist with propensity for accumulation and responsiveness in ileum |
|
DCC2124 |
fli-28 |
Novel inhibitor of general secretion in early stage; FLI-06 analogue twice as active as FLI-06 |
|
DCC2125 |
Flll11 |
Curcumin analogue, exhibiting enhanced growth-suppressive activity and inhibiting AKT and signal transducer and activator of transcription 3 phosphorylation in breast and prostate cancer cells |
|
DCC2126 |
Flll12 |
Curcumin analogue, exhibiting enhanced growth-suppressive activity and inhibiting AKT and signal transducer and activator of transcription 3 phosphorylation in breast and prostate cancer cells |
|
DCC2127 |
flll62 |
Inhibitor of STAT3 phosphorylation and apoptotic promoter of human renal cell carcinoma and melanoma cell lines |
|
DCC2128 |
Flortanidazole |
Tumour hypoxia probe |
|
DCC2129 |
Flt3 Inhibitor 17 |
Novel FLT3 inhibitor, displaying potent inhibitory activity against the FLT3-ITD mutant (IC 50 = 0.8 nM) and good selectivity over c-KIT kinase (over 500-fold), selectively inhibiting the proliferation of FLT3-ITD-positive AML cell lines MV4-11 (IC 50 = 2 |
|
DCC2130 |
Flt3 Inhibitor Iv |
Novel potent ATP-competitive inhibitor of Flt3 |
|
DCC2131 |
Flt3-in-50 |
Novel selective and efficacious inhibitor of FLT3 mutations |
|
DCC2132 |
fluacrypyrim |
Novel STAT3 activation inhibitor, induces cell cycle arrest and apoptosis in cancer cells harboring constitutively-active STAT3 |
|
DCC2133 |
Flubendiamide |
The first phthalic acid diamide insecticide, impairs neuronal calcium signalling in the honey bees antennae |
|
DCC2134 |
flu-dnb |
Novel photolabile NO donor |
|
DCC2135 |
Flufenacet |
Herbicide, inhibiting very-long-chain fatty acid elongase (VLCFAE) synthesis |
|
DCC2136 |
Fluo-3 |
Green-fluorescent intracellular calcium indicator |
|
DCC2137 |
Fluo-3 Am |
Green-fluorescent intracellular calcium indicator |
|
DCC2138 |
Fluoroclorgyline |
Monoamine oxidase A (MAO-A) specific inhibitor |
|
DCC2139 |
Fluoroethylnormemantine |
Novel potent neuroprotective agent for treatment of Alzheimer's disease (AD), targeting NMDA receptor |
|
DCC2140 |
Fluoroethylnormemantine Hcl |
Novel potent neuroprotective agent for treatment of Alzheimer's disease (AD), targeting NMDA receptor |
|
DCC2141 |
fluoxatrobin |
Fungicide for the control of fungal diseases such as early blight, late blight, leaf spots, leaf rust, and Rhizoctonia solani. |
|
DCC2142 |
Fluperlapine |
Atypical antipsychotic agent and ligand for the serotonin receptors 5-HT6/5-HT7 |
|
DCC2143 |
Fluphenazine Decanoate |
Antipsychotic agent, blocking postsynaptic dopamine D2 receptors in the limbic, cortical system and basal ganglia |
|
DCC2144 |
Fluphenazine Decanoate Dihydrochloride |
Antipsychotic agent, blocking postsynaptic dopamine D2 receptors in the limbic, cortical system and basal ganglia |
|
DCC2145 |
Flutazolam |
Benzodiazepine with sedative, muscle relaxant, anticonvulsant, and anxiolytic activities |
|
DCC2146 |
Flutonidine |
alpha2-Adrenergic receptor agonist |
|
DCC2147 |
Fm4-64 |
Fluorescent probe for monitoring synaptic activity at neuromuscular junctions |
|